GELS
Gelteq Limited Ordinary Shares
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$0.90
+0.76%Margins
Gross margin
100.0%
EBITDA margin
-2174.9%
EBIT margin
-8181.2%
Net margin
-3137.1%
FCF margin
-3451.4%
-39.5%
Return on equity
-27.8%
Return on assets
-75.6%
Return on invested capital
—
Asset turnover
-$4.0M
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025